Literature DB >> 16258057

Body mass index and mortality from ischaemic heart disease in a lean population: 10 year prospective study of 220,000 adult men.

Zhengming Chen1, Gonghuan Yang, Maigeng Zhou, Margaret Smith, Alison Offer, Jieming Ma, Lijun Wang, Hongchao Pan, Gary Whitlock, Rory Collins, Shiru Niu, Richard Peto.   

Abstract

BACKGROUND: Increased body mass index (BMI) is known to be related to ischaemic heart disease (IHD) in populations where many are overweight (BMI>or=25 kg/m2) or obese (BMI>or=30). Substantial uncertainty remains, however, about the relationship between BMI and IHD in populations with lower BMI levels.
METHODS: We examined the data from a population-based, prospective cohort study of 222,000 Chinese men aged 40-79. Relative and absolute risks of death from IHD by baseline BMI were calculated, standardized for age, smoking, and other potential confounding factors.
RESULTS: The mean baseline BMI was 21.7 kg/m2, and 1942 IHD deaths were recorded during 10 years of follow-up (6.5% of all such deaths). Among men without prior vascular diseases at baseline, there was a J-shaped association between BMI and IHD mortality. Above 20 kg/m2 there was a positive association of BMI with risk, with each 2 kg/m2 higher in usual BMI associated with 12% (95% CI 6-19%, 2P=0.0001) higher IHD mortality. Below this BMI range, however, the association appeared to be reversed, with risk ratios of 1.00, 1.09, and 1.15, respectively, for men with BMI 20-21.9, 18-19.9, and <18 kg/m2. The excess IHD risk observed at low BMI levels persisted after restricting analysis to never smokers or excluding the first 3 years of follow-up, and became about twice as great after allowing for blood pressure.
CONCLUSIONS: Lower BMI is associated with lower IHD risk among people in the so-called normal range of BMI values (20-25 kg/m2), but below that range the association may well be reversed.

Entities:  

Mesh:

Year:  2005        PMID: 16258057     DOI: 10.1093/ije/dyi215

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  14 in total

1.  Metabolic cardiovascular risk factors worsen continuously across the spectrum of body mass index in Asian Indians.

Authors:  Rajeev Gupta; Aachu Agrawal; Anoop Misra; Soneil Guptha; Naval K Vikram
Journal:  Indian Heart J       Date:  2012 May-Jun

2.  Body mass index and incident coronary heart disease in women: a population-based prospective study.

Authors:  Dexter Canoy; Benjamin J Cairns; Angela Balkwill; F Lucy Wright; Jane Green; Gillian Reeves; Valerie Beral
Journal:  BMC Med       Date:  2013-04-02       Impact factor: 8.775

3.  Which psychological, psychophysiological, and anthropometric factors are connected with life events, depression, and quality of life in patients with cardiovascular disease.

Authors:  Milos Slepecky; Antonia Kotianova; Jan Prasko; Ivan Majercak; Erika Gyorgyova; Michal Kotian; Marta Zatkova; Marta Popelkova; Marie Ociskova; Ingrid Tonhajzerova
Journal:  Neuropsychiatr Dis Treat       Date:  2017-08-04       Impact factor: 2.570

4.  Impact of cigarette smoking on the relationship between body mass index and coronary heart disease: a pooled analysis of 3264 stroke and 2706 CHD events in 378579 individuals in the Asia Pacific region.

Authors: 
Journal:  BMC Public Health       Date:  2009-08-13       Impact factor: 3.295

5.  Synergistic and Non-synergistic Associations for Cigarette Smoking and Non-tobacco Risk Factors for Cardiovascular Disease Incidence in the Atherosclerosis Risk In Communities (ARIC) Study.

Authors:  Jay H Lubin; David Couper; Pamela L Lutsey; Hiroshi Yatsuya
Journal:  Nicotine Tob Res       Date:  2017-07-01       Impact factor: 4.244

6.  Who is maintaining weight in a middle-aged population in Sweden? A longitudinal analysis over 10 years.

Authors:  Anne N Nafziger; Kristina Lindvall; Margareta Norberg; Hans Stenlund; Stig Wall; Paul L Jenkins; Thomas A Pearson; Lars Weinehall
Journal:  BMC Public Health       Date:  2007-06-12       Impact factor: 3.295

7.  Better Adherence to the Mediterranean Diet Could Mitigate the Adverse Consequences of Obesity on Cardiovascular Disease: The SUN Prospective Cohort.

Authors:  Sonia Eguaras; Estefanía Toledo; Aitor Hernández-Hernández; Sebastián Cervantes; Miguel A Martínez-González
Journal:  Nutrients       Date:  2015-11-05       Impact factor: 5.717

Review 8.  Association between body mass index and cardiovascular disease mortality in east Asians and south Asians: pooled analysis of prospective data from the Asia Cohort Consortium.

Authors:  Yu Chen; Wade K Copeland; Rajesh Vedanthan; Eric Grant; Jung Eun Lee; Dongfeng Gu; Prakash C Gupta; Kunnambath Ramadas; Manami Inoue; Shoichiro Tsugane; Akiko Tamakoshi; Yu-Tang Gao; Jian-Min Yuan; Xiao-Ou Shu; Kotaro Ozasa; Ichiro Tsuji; Masako Kakizaki; Hideo Tanaka; Yoshikazu Nishino; Chien-Jen Chen; Renwei Wang; Keun-Young Yoo; Yoon-Ok Ahn; Habibul Ahsan; Wen-Harn Pan; Chung-Shiuan Chen; Mangesh S Pednekar; Catherine Sauvaget; Shizuka Sasazuki; Gong Yang; Woon-Puay Koh; Yong-Bing Xiang; Waka Ohishi; Takashi Watanabe; Yumi Sugawara; Keitaro Matsuo; San-Lin You; Sue K Park; Dong-Hyun Kim; Faruque Parvez; Shao-Yuan Chuang; Wenzhen Ge; Betsy Rolland; Dale McLerran; Rashmi Sinha; Mark Thornquist; Daehee Kang; Ziding Feng; Paolo Boffetta; Wei Zheng; Jiang He; John D Potter
Journal:  BMJ       Date:  2013-10-01

9.  The morbidity rate of chronic disease among Chinese rural residents: results from Liuyang cohort.

Authors:  Xin Huang; Mengshi Chen; Hongzhuan Tan; Shuiyuan Xiao; Jing Deng
Journal:  Med Princ Pract       Date:  2013-01-25       Impact factor: 1.927

10.  Adiposity and risk of ischaemic and haemorrhagic stroke in 0·5 million Chinese men and women: a prospective cohort study.

Authors:  Zhengming Chen; Andri Iona; Sarah Parish; Yiping Chen; Yu Guo; Fiona Bragg; Ling Yang; Zheng Bian; Michael V Holmes; Sarah Lewington; Ben Lacey; Ruqin Gao; Fang Liu; Zengzhi Zhang; Junshi Chen; Robin G Walters; Rory Collins; Robert Clarke; Richard Peto; Liming Li
Journal:  Lancet Glob Health       Date:  2018-06       Impact factor: 26.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.